Literature DB >> 23208702

Radiolabelled white blood cell scintigraphy in the work-up of dermal filler complications.

F R Grippaudo1, M Pacilio, M Di Girolamo, R A Dierckx, A Signore.   

Abstract

PURPOSE: Scintigraphy with radiolabelled autologous white blood cells (WBC) is a widely used method for the detection of sites of infection. In this study we evaluated the role of WBC scintigraphy in the diagnosis and follow-up of patients with suspected soft tissue infection caused by dermal fillers in the face. We compared several qualitative and quantitative interpretation criteria and the results obtained with MRI and high-frequency US (HFUS).
METHODS: Between 2007 and 2011, ten consecutive patients (all women) aged between 25 and 65 years showing a reaction to dermal fillers were enrolled in the study. In five of these patients WBC scintigraphy was repeated at the end of therapy. Scintigraphy with (99m)Tc-HMPAO-labelled WBC was performed in each patient acquiring planar and SPECT images at 3 h and 20 h as well as HFUS with Doppler analysis and MRI with Gd-DTPA. The final diagnosis was determined by fine-needle aspiration and microbiological analysis of lesions in eight patients (before therapy in six and after therapy in two) and by clinical data and follow-up (at least 1 year) in seven patients (before therapy in four and after therapy in three). Two patients were treated with steroids, and the others were treated with antibiotics for 3 weeks. Several qualitative and semiquantitative interpretation criteria were applied to define the best strategy for accurate diagnosis of infections, implemented by SPECT images in patients with doubtful planar scans. The WBC scintigraphy results were also compared with the MRI and HFUS results.
RESULTS: Sensitivity, specificity and accuracy were respectively 90 %, 100 % and 93.3 % for WBC scintigraphy with qualitative and semiquantitative interpretation of planar images and 100 %, 100 % and 100 % with qualitative analysis of SPECT images. Sensitivity, specificity and accuracy for HFUS were 44 %, 66 % and 50 %, and for MRI were 50 %, 100 % and 67.6 %, respectively. Scans performed after therapy in five patients were negative in three and still positive in two (all true results).
CONCLUSION: In conclusion, scintigraphy with radiolabelled WBC was found to be the most accurate method for diagnosing infection in patients with long-term dermal filler complications, particularly using qualitative analysis of SPECT images. No differences were observed with planar images using either qualitative or semiquantitative analysis. HFUS and MRI may provide additional important information for defining the nature of the filler and for surgery, but are not accurate enough for diagnosing infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23208702     DOI: 10.1007/s00259-012-2305-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  24 in total

Review 1.  Avoiding and treating dermal filler complications.

Authors:  Gottfried Lemperle; Peter P Rullan; Nelly Gauthier-Hazan
Journal:  Plast Reconstr Surg       Date:  2006-09       Impact factor: 4.730

Review 2.  Fever of unknown origin, infection of subcutaneous devices, brain abscesses and endocarditis.

Authors:  Giuseppe Lucio Cascini; Diego De Palma; Federica Matteucci; Alberto Biggi; Pier Francesco Rambaldi; Alberto Signore; Luigi Mansi
Journal:  Nucl Med Commun       Date:  2006-03       Impact factor: 1.690

Review 3.  Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers.

Authors:  Lise Hanne Christensen
Journal:  Dermatol Surg       Date:  2009-10       Impact factor: 3.398

4.  The utility of high-frequency ultrasound in dermal filler evaluation.

Authors:  Francesca Romana Grippaudo; Mauro Mattei
Journal:  Ann Plast Surg       Date:  2011-11       Impact factor: 1.539

Review 5.  Infected facial tissue fillers: case series and review of the literature.

Authors:  Petr Schütz; Hussein Hassan Hamed Ibrahim; Sabreyah Saleh Hussain; Tamer Sabry Ali; Khalid El-Bassuoni; John Thomas
Journal:  J Oral Maxillofac Surg       Date:  2012-02-17       Impact factor: 1.895

6.  Chronic prosthetic vascular graft infection visualized with technetium-99m-hexamethylpropyleneamine oxime-labeled leukocytes.

Authors:  M Vorne; R Laitinen; T Lantto; K Järvi; I Toivio; R Mokka
Journal:  J Nucl Med       Date:  1991-07       Impact factor: 10.057

Review 7.  Injectable soft-tissue fillers: clinical overview.

Authors:  Barry L Eppley; Babak Dadvand
Journal:  Plast Reconstr Surg       Date:  2006-09-15       Impact factor: 4.730

8.  Complicated bone and soft-tissue infections. Imaging with 0.1 T MR and 99mTc-HMPAO-labeled leukocytes. ff.

Authors:  I Hovi
Journal:  Acta Radiol       Date:  1996-11       Impact factor: 1.990

9.  Technetium-99m HM-PAO-labeled leukocytes in detection of inflammatory lesions: comparison with gallium-67 citrate.

Authors:  M Vorne; I Soini; T Lantto; S Paakkinen
Journal:  J Nucl Med       Date:  1989-08       Impact factor: 10.057

10.  Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophy.

Authors:  Jeya T Nadarajah; Micaela Collins; Janet Raboud; DeSheng Su; Kavya Rao; Mona R Loutfy; Sharon Walmsley
Journal:  Clin Infect Dis       Date:  2012-08-31       Impact factor: 9.079

View more
  9 in total

1.  Image acquisition and interpretation criteria for 99mTc-HMPAO-labelled white blood cell scintigraphy: results of a multicentre study.

Authors:  Paola A Erba; Andor W J M Glaudemans; Niels C Veltman; Martina Sollini; Marta Pacilio; Filippo Galli; Rudi A J O Dierckx; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-26       Impact factor: 9.236

2.  Comment on Grippaudo et al.: Radiolabelled white blood cell scintigraphy in the work-up of dermal filler complications.

Authors:  Tae Hwan Park
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-22       Impact factor: 9.236

3.  MRI in the evaluation of facial dermal fillers in normal and complicated cases.

Authors:  Marco Di Girolamo; Mauro Mattei; Alberto Signore; Francesca Romana Grippaudo
Journal:  Eur Radiol       Date:  2014-12-05       Impact factor: 5.315

Review 4.  Managing Complications of Fillers: Rare and Not-So-Rare.

Authors:  Eckart Haneke
Journal:  J Cutan Aesthet Surg       Date:  2015 Oct-Dec

5.  Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline.

Authors:  A Signore; F Jamar; O Israel; J Buscombe; J Martin-Comin; E Lazzeri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-31       Impact factor: 9.236

Review 6.  Nonvascular Complications of Injectable Fillers-Prevention and Management.

Authors:  Kuldeep Singh; Shahin Nooreyezdan
Journal:  Indian J Plast Surg       Date:  2020-12-24

7.  A Cross-sectional Analysis of Adverse Events and Litigation for Injectable Fillers.

Authors:  Hani M Rayess; Peter F Svider; Curtis Hanba; Vivek Sagar Patel; Louis M DeJoseph; Michael Carron; Giancarlo F Zuliani
Journal:  JAMA Facial Plast Surg       Date:  2018-05-01       Impact factor: 4.611

Review 8.  Dermal fillers in aesthetics: an overview of adverse events and treatment approaches.

Authors:  David Funt; Tatjana Pavicic
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-12-12

9.  Skin bacterial flora as a potential risk factor predisposing to late bacterial infection after cross-linked hyaluronic acid gel augmentation.

Authors:  Irina Netsvyetayeva; Wojciech Marusza; Romuald Olszanski; Kamila Szyller; Aneta Krolak-Ulinska; Ewa Swoboda-Kopec; Janusz Sierdzinski; Zachary Szymonski; Grazyna Mlynarczyk
Journal:  Infect Drug Resist       Date:  2018-02-12       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.